Clinical Trial Fraud: ‘Specter of Impact’ For Big Pharma Companies

 
• By Brenda Sandburg

While small CROs have so far been the targets, former US Department of Justice official says sponsors could face enforcement action if they fail to vet them. FDA is developing policies in parallel with DOJ’s criminal initiative.

Fraud
DOJ and FDA are pursuing clinical trial fraud in parallel efforts. • Source: Shutterstock

More from Clinical Trials

More from R&D